Don't even think about selling those shares for the rest of the month. Add on any weakness, if you can. Nice to see you again my friend. Hope life has been treating you well! I post VERY infrequently on ET. But I do check my e-mail from time to time.
Hey Wags. Yeah, I haven't seen any posts from you in awhile. I've got limits under the market. I'm about half of size I'd like. Looking for 17-22 after the release. I hope you got that clearing issue resolved.
Someone help me with this as I am now in size in EXAS. What's the value-add to this test over something like this? http://www.drugstore.com/products/p...=goobase_filler&device=c&network=g&matchtype= Partially joking, and I understand that this is also a quick methylation test.
sometimes no matter how high the premium is priced, it can be cheap.. i was thinking of taking a long shot with otm calls..
The home test and the lab test done when you have your normal checkup just looks for blood in your stool. It will usually only catch later stage cancers which have already high mortality rates. I am not long stock but short puts and long covered calls because I think the FDA is going to be cautious about approving the EXAS test since it is the first of the DNA marker tests. DNA market diagnostic tests will surely be common in the future. So I think the FDA is not going to want to make any mistake. The current test is just a larger version of a previous test that had very good results but if there is a few percent lower value anywhere. Very possible just from mechanics of a new test, stock may not rise much. The alternative which seems to work better for some types of cancer (not Colon cancer) is blood DNA tests which could replace the EXAS test.
Yeah, I realize this is a multi-faceted methlyation (et al) test. I am a bit concerned on the 57% figure on PC growths under 3CM. The convenience of the stool test beats out blood.